​

Ikena Oncology (IKNA) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

IKNA Stock Forecast

Ikena Oncology (IKNA) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $1.33, with a high of $1.33 and a low of $1.33. This represents a 19.82% increase from the last price of $1.11.

High: $1.33 Avg: $1.33 Low: $1.33 Last Closed Price: $1.11

IKNA Stock Rating

Ikena Oncology stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (80.00%), 1 Hold (20.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 1 4 Strong Sell Sell Hold Buy Strong Buy

IKNA Price Target Upside V Benchmarks

TypeNameUpside
StockIkena Oncology19.82%
SectorHealthcare Stocks 33.91%
IndustryBiotech Stocks 83.49%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$1.67
Last Closing Price$1.11$1.11$1.11
Upside/Downside--50.45%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25111--3
Mar, 25111--3
Feb, 25111--3
Jan, 25111--3
Dec, 24111--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 29, 2024David NierengartenWedbush$1.33$1.64-18.90%19.82%
May 29, 2024David NierengartenWedbush$2.00$1.3350.38%80.18%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 29, 2024William BlairOutperformOutperformhold
May 29, 2024Cowen & Co.BuyBuyhold
May 29, 2024Wells FargoUnderweightdowngrade
May 29, 2024WedbushOutperformNeutraldowngrade
May 29, 2024H.C. WainwrightBuyBuyhold
May 14, 2024WedbushBuyOutperforminitialise
Mar 19, 2024WedbushBuyBuyhold
Jan 19, 2024WedbushOutperformOutperformhold
Sep 22, 2023WedbushOutperforminitialise
Mar 15, 2023Credit SuisseOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.95$-1.84$-1.63$-1.02----
Avg Forecast$-2.71$-1.62$-1.62$-1.17$-1.03$-1.00$-1.10$-0.96
High Forecast$-2.71$-1.62$-1.57$-1.09$-0.85$-0.68$-0.65$-0.96
Low Forecast$-2.71$-1.62$-1.69$-1.22$-1.23$-1.28$-1.68$-0.96
Surprise %-64.94%13.58%0.62%-12.82%----

Revenue Forecast

$0 $7M $14M $21M $28M $35M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$30.98M$15.62M$9.16M-----
Avg Forecast$15.56M$16.18M$11.87M$3.50M$3.50M$3.50M$3.50M$18.50M
High Forecast$15.56M$16.18M$15.32M$3.50M$3.50M$3.50M$3.50M$18.50M
Low Forecast$15.56M$16.18M$8.99M$3.50M$3.50M$3.50M$3.50M$18.50M
Surprise %99.12%-3.50%-22.84%-----

Net Income Forecast

$-115M $-97M $-79M $-61M $-43M $-25M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-34.12M$-66.63M$-68.17M$-49.23M----
Avg Forecast$-112.98M$-67.45M$-68.17M$-48.18M$-44.14M$-40.89M$-48.68M$-40.07M
High Forecast$-112.98M$-67.45M$-65.68M$-45.47M$-35.65M$-28.49M$-27.14M$-40.07M
Low Forecast$-112.98M$-67.45M$-70.66M$-50.90M$-51.38M$-53.30M$-70.21M$-40.07M
Surprise %-69.80%-1.21%-2.18%----

IKNA Forecast FAQ

Is Ikena Oncology stock a buy?

Ikena Oncology stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Ikena Oncology is a favorable investment for most analysts.

What is Ikena Oncology's price target?

Ikena Oncology's price target, set by 5 Wall Street analysts, averages $1.33 over the next 12 months. The price target range spans from $1.33 at the low end to $1.33 at the high end, suggesting a potential 19.82% change from the previous closing price of $1.11.

How does Ikena Oncology stock forecast compare to its benchmarks?

Ikena Oncology's stock forecast shows a 19.82% upside, underperforming the average forecast for the healthcare stocks sector (33.91%) and underperforming the biotech stocks industry (83.49%).

What is the breakdown of analyst ratings for Ikena Oncology over the past three months?

  • April 2025: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is Ikena Oncology’s EPS forecast?

Ikena Oncology's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.03, marking a 0.98% increase from the reported $-1.02 in 2024. Estimates for the following years are $-1 in 2026, $-1.1 in 2027, and $-0.96 in 2028.

What is Ikena Oncology’s revenue forecast?

Ikena Oncology's average annual revenue forecast for its fiscal year ending in December 2025 is $3.5M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $3.5M, followed by $3.5M for 2027, and $18.5M for 2028.

What is Ikena Oncology’s net income forecast?

Ikena Oncology's net income forecast for the fiscal year ending in December 2025 stands at $-44.143M, representing a -10.34% decrease from the reported $-49.234M in 2024. Projections indicate $-40.893M in 2026, $-48.676M in 2027, and $-40.066M in 2028.